SCHEMBL6433920

SCHEMBL6433920

NC(=S)c1cccc(Cn2c(C(=O)O)cc3c(O)cccc32)c1

nearest known ligand 0.67

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.67
F2 P00734 5/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6439390 0.88 F10 (0.85) F10F2
SCHEMBL6437276 0.86 F10 (0.81) F10F2
SCHEMBL27497454 0.83 PLA2G10 (0.74) F10F2
SCHEMBL6432562 0.83 F10 (0.79) F10F2
SCHEMBL7424420 0.80 F10 (0.73) F10F2
SCHEMBL6433052 0.78 F10 (0.63) F10F2
SCHEMBL6432935 0.78 CCR2 (0.64) F10F2
SCHEMBL6308083 0.77 CCR2 (0.81) F10
SCHEMBL12589593 0.76 F10 (1.00) F10F2
SCHEMBL3963187 0.74 PLA2G10 (0.83) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042287-B1 INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA AVENTIS PHARMA GMBH (DE) 2005-04-20 EP disclosed
US-6337344-B1 ANTICOAGULANTS AND ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-01-08 US disclosed
EP-1042287-A1 INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA Aventis Pharma Deutschland GmbH (DE) 2000-10-11 EP disclosed
WO-1999033800-A1 INDOLE DERIVATIVES AS INHIBITORS OR FACTOR XA AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 1999-07-08 WO disclosed